Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program.

Autor: Gelbenegger G; Department of Clinical Pharmacology., Schoergenhofer C; Department of Clinical Pharmacology., Derhaschnig U; Department of Emergency Medicine., Buchtele N; Department of Internal Medicine I, and., Sillaber C; Division of Hematology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Fillitz M; Department of Internal Medicine, Hanusch Krankenhaus, Vienna, Austria., Schenk TM; Department of Internal Medicine, Universitätsklinikum St. Pölten, St. Pölten, Austria., D'Sa S; University College London Hospitals (UCLH) Centre for Waldenströms Macroglobulinaemia and Related Conditions, UCLH, National Health Service (NHS) Foundation Trust, London, United Kingdom., Cartwright R; Worthing Hospital, Western Sussex Hospitals, NHS Foundation Trust, Worthing, United Kingdom; and., Gilbert JC; Band Therapeutics, LLC, Lexington, MA., Jilma B; Department of Clinical Pharmacology., Jaeger U; Division of Hematology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Publikováno v: Blood advances [Blood Adv] 2020 Mar 24; Vol. 4 (6), pp. 997-1005.

FLP/FRT recombination from yeast: application of a two gene cassette scheme as an inducible system in plants.

Autor: Rao MR; Department of Plant Sciences, University of Tennessee, Knoxville, TN 37996, USA. mraghave@utk.edu, Moon HS, Schenk TM, Becker D, Mazarei M, Stewart CN Jr

Publikováno v: Sensors (Basel, Switzerland) [Sensors (Basel)] 2010; Vol. 10 (9), pp. 8526-35. Date of Electronic Publication: 2010 Sep 13.

Therapeutic cloning.

Autor: Schenk TM

Publikováno v: The New England journal of medicine [N Engl J Med] 2002 Nov 14; Vol. 347 (20), pp. 1619-22; author reply 1619-22.

Identification and functional characterization of multiple inositol polyphosphate phosphatase1 (Minpp1) isoform-2 in exosomes with potential to modulate tumor microenvironment.

Autor: Zubair, Mohd¹ (AUTHOR) nali@ualr.edu, Hamzah, Rabab^2,3 (AUTHOR), Griffin, Robert² (AUTHOR), Ali, Nawab¹ (AUTHOR) nali@ualr.edu

Publikováno v: PLoS ONE. 3/2/2022, Vol. 17 Issue 3, p1-25. 25p.

Recurrent lymphoid and myeloid relapses due to treatment cessations reveal natural history of Ph-positive B-ALL and pose a diagnostic challenge.

Autor: Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour EJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu CY; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Apr; Vol. 99 (4), pp. 721-726. Date of Electronic Publication: 2024 Jan 19.